Health tech companies made several major funding announcements in April. Here is a list of some of the biggest funding rounds. The post 4 Notable Health Tech Funding Announcements in April appeared first on MedCity News.
KalVista Pharmaceuticals brings to Chiesi Group the product Ekterly, the first FDA-approved oral drug for acute treatment of swelling attacks from the rare disease hereditary angioedema. Ekterly’s tablet formulation offers a dosing edge compared to injectable HAE medications. The post Chiesi Group Grows Again in Rare Disease With $1.9B KalVista Acquisition appeared first on MedCity…
Layoffs tied to AI adoption will not be uniform; they will vary by sector, job function, and regulatory exposure. Nowhere is this more complex than in healthcare, where legal constraints, patient safety obligations, and labor dynamics intersect with rapid technological change. The post AI-Driven Layoffs In Healthcare: Navigating Legal Risks and Operational Challenges appeared first…
Financial assistance is moving from discretionary policy to regulated infrastructure. For health systems, that shift has significant operational and financial implications. The post Financial Assistance Reform Is Reshaping Revenue Cycle Strategy appeared first on MedCity News.
In today’s cash- and staffing-strapped, high-stakes healthcare environment, COEs are an operational necessity. The most successful organizations treat them as long-term strategic investments, or engines for scalable, sustainable transformation. The post Beyond Support Teams: The Strategic Role of Centers of Excellence in Healthcare appeared first on MedCity News.
Medtronic suffered a cyberattack on its corporate IT systems. The incident highlights growing cybersecurity risks in the medtech sector, with cybergangs increasingly using phishing and other human-engineering tactics to gain access to data. The post 6 Things to Know About Medtronic’s Cyberattack appeared first on MedCity News.
Lawmakers introduced the Medicare Advantage Improvement Act of 2026 to tighten prior authorization rules, boost transparency and curb practices that delay care. The post Bipartisan Bill Seeks to Strengthen Oversight of Medicare Advantage appeared first on MedCity News.
Coultreon Biopharma’s lead drug candidate, acquired from Galapagos, is a small molecule designed to selectively inhibit a novel immunology target called SIK3. The Series A financing will support Phase 2 clinical trials in psoriasis and ulcerative colitis. The post Immunology-Focused Coultreon Adds $125M for Pills That Pack the Punch of Injectable Biologics appeared first on…
As biologics modalities diversify and processes grow complex, the success of tech transfer depends on integrated execution rather than each procedural completion. The post Executing Biologics Technology Transfer through Integrated Operating Models appeared first on MedCity News.
Many health plans are discovering that even after digitizing medical policies and implementing FHIR APIs, prior authorization turnaround times remain slow and provider frustration remains high. The reason is straightforward: digitization alone does not make medical‑necessity determinations executable by automated systems at scale. The post Digitizing Medical Policy Alone Will Not Automate Prior Authorization at…